Women who have premature menopause due to medical interventions are at an increased risk of developing lung cancer, says a new study.
Women who have premature menopause due to medical interventions are at an increased risk of developing lung cancer, says a new study.
The study has been published in the International Journal of Cancer.The startling link was made by epidemiologists from the Universite de Montreal, the Research Centre of the Centre Hospitalier de l'Universite de Montreal and the INRS-Institut Armand-Frappier.
"We found that women who experienced non-natural menopause are at almost twice the risk of developing lung cancer compared to women who experienced natural menopause," says Anita Koushik, a researcher at the Universite de Montreal's Department of Social and Preventive Medicine and a scientist at the Research Centre of the Centre Hospitalier de l'Universite de Montreal.
"This increased risk of lung cancer was particularly observed among women who had non-natural menopause by having had both their ovaries surgically removed," the expert added.
To reach the conclusion, the scientists studied 422 women with lung cancer and 577 control subjects at 18 hospitals across Montreal, Quebec, Canada. They assessed socio-demographic characteristics, residential history, occupational exposures, medical and smoking history, and (among women) menstruation and pregnancy histories.
"A major strength of this study was the detailed smoking information which we obtained from all study participants; this is important because of the role of smoking in lung cancer and because smokers generally have lower estrogen levels than non-smokers," Koushik said.
Advertisement
Women were considered menopausal if their menstrual periods had stopped naturally, surgically or because of radiation or chemotherapy.
Advertisement
"Non-natural menopause, particularly surgical menopause, may represent an increased risk with younger age at menopause given that surgery is usually done before natural menopause occurs.
It's possible that vulnerability to lung cancer is caused by early and sudden decrease in estrogen levels or potentially long-term use of hormone replacement therapy and further research is needed to explore these hypotheses," says Jack Siemiatycki a professor at the Universite de Montreal's Department of Social and Preventive Medicine and a scientist at the Research Centre of the Centre Hospitalier de l'Universite de Montreal.
Source-ANI
LIN